TMO
Thermo Fisher Scientific Inc
665.30$
+1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.4% | +7.7% | +14.5% | +16.4% | +4.9% | +26.1% | +21.7% | +14.5% | -4.6% | +0.1% | +3.9% | |
| – | +1.4% | +6.2% | +16.0% | +19.0% | +6.2% | +14.0% | +20.9% | +32.3% | -2.4% | -0.6% | +10.4% | |
| – | -0.6% | +9.5% | +12.8% | +13.5% | +3.2% | +41.3% | +22.5% | -3.2% | -7.6% | +0.9% | -5.4% | |
| – | +0.2% | +9.0% | +17.6% | +8.9% | +3.7% | +17.7% | +19.1% | +4.6% | -9.1% | +4.0% | +0.5% | |
| – | -5.8% | +7.9% | +10.4% | +10.3% | +1.4% | +12.8% | -1.3% | +4.2% | +20.8% | -0.2% | -15.4% | |
| – | -3.5% | +7.1% | +12.0% | +11.0% | -0.4% | +14.7% | +14.6% | +12.6% | +2.1% | -6.0% | -13.9% | |
| – | +6.2% | +14.6% | +14.3% | +18.5% | +10.0% | +85.4% | +30.7% | -17.4% | -19.5% | +11.7% | +5.8% | |
| – | -13.5% | +13.2% | +26.1% | +12.7% | +1.3% | -18.2% | -3.1% | +35.4% | +89.4% | +20.3% | -14.2% | |
| – | -7.2% | +4.5% | +20.0% | +34.3% | +24.8% | +77.6% | +22.3% | -13.3% | -17.8% | +11.1% | +3.9% | |
| – | -122.9% | – | – | +61.2% | +15.4% | +127.3% | +30.5% | -36.6% | -140.4% | – | -16.7% | |
| – | +4.3% | +2.3% | +10.1% | +32.0% | +25.8% | +72.5% | +21.2% | -10.0% | -13.7% | +5.7% | +6.3% | |
| – | -5.0% | +5.2% | +18.9% | +22.6% | +13.4% | +43.9% | +18.4% | -0.2% | -42.6% | +72.0% | -2.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.